Regenerative Applications Of Placental Tissue Allografts With Dr. Bruce Werber
I had the privilege of speaking with Dr. Bruce Werber about the innovative use of placental tissue allografts in regenerative medicine. With 35 years of experience as a board-certified foot and ankle surgeon, Dr. Werber also serves as the COO of BioTech Products, Services, and Research (BPSR) and the CEO of its subsidiary, Anu Life Sciences.
Cryo-Cell to Spin-off Celle Corp., Its Subsidiary Holding Assets Not Directly Associated with Recurring Revenue from Biopreservation
Celle Corp. holds certain assets of Cryo-Cell not directly associated with its recurring revenue derived from privately banked cord blood specimens.
OLDSMAR, Fla.–Cryo-Cell International, Inc. (NYSE American LLC: CCEL), the world’s first private cord blood bank to separate and store stem cells in 1992, announced that its Board of Directors has authorized the spin-off of its newly formed subsidiary, Celle Corp., to the Cryo-Cell shareholders and to explore all strategic alternatives for Cryo-Cell (post spin-off) to maximize shareholder value, including, but not limited to, equity and/or debt financings and/or the possible sale or merger of the company. There is no assurance that such a transaction will take place. [Read more…]
Fiocruz and Caring Cross To Offer Drastically More Affordable CAR-T Therapy in Brazil and Latin America
Local production will permit CAR-T treatment to be available free of charge to patients.
The cost to the Brazilian public health system will be slashed to 10% of the amount currently charged in Europe and the USA (only US$35,000 per dose).
RIO DE JANEIRO and GAITHERSBURG, Md., March 26, 2024 — Fundação Oswaldo Cruz (Fiocruz), a foundation from the Brazilian government’s Ministry of Health, and Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to advanced medicinal cures for all patients, everywhere, today announced a collaboration to develop local manufacturing of chimeric antigen receptor (CAR)-T cell and stem cell gene therapies for oncology, infectious, and genetic diseases in Brazil, including CAR-T cell therapies for leukemia, lymphoma, and HIV infection. [Read more…]
Defined Bioscience Introduces Ready-CEPT™: A New Cell Viability Enhancer
Defined Bioscience is pleased to announce the launch of Ready-CEPT™ 1000X, a new product designed to improve stem cell survival, growth, and health during critical processes such as routine passaging, cryopreservation, and freeze-thaw recovery.
San Diego, CA, April 1, 2024 – Defined Bioscience is pleased to announce the launch of Ready-CEPT™ 1000X, a new product designed to improve stem cell survival, growth, and health during critical processes such as routine passaging, cryopreservation, and freeze-thaw recovery. This product introduces a reliable solution for researchers in stem cell research and biotechnology, focusing on enhancing cell viability. [Read more…]
- « Previous Page
- 1
- …
- 96
- 97
- 98
- 99
- 100
- …
- 334
- Next Page »